Twitter

MLN9708 and Dexamethasone for High-Risk Smoldering Multiple Myeloma

Condition:   Multiple Myeloma
Interventions:   Drug: MLN9708;   Drug: Dexamethasone
Sponsors:   National Institutes of Health Clinical Center (CC);   National Cancer Institute (NCI)
Recruiting – verified July 2012

Read the original here: MLN9708 and Dexamethasone for High-Risk Smoldering Multiple Myeloma




Comments are closed.